Clinical Trials in Nagpur, India
Locations / Nagpur, India
Delta Trials records 612 clinical trials conducted in Nagpur, India, making it a notable site of clinical research activity. These trials across 442 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 57 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Nagpur has changed over time.
612
Total Trials
442
Conditions
57
Terminated since 2020
Browse by condition (442 total)
- Diabetes mellitus, type 2 41 trialsAll Diabetes mellitus, type 2 trials
- Asthma 26 trialsAll Asthma trials
- Breast cancer 16 trialsAll Breast cancer trials
- Type 2 diabetes mellitus 15 trialsAll Type 2 diabetes mellitus trials
- Acute coronary syndrome 14 trialsAll Acute coronary syndrome trials
- Ulcerative colitis 14 trialsAll Ulcerative colitis trials
- Obesity 14 trialsAll Obesity trials
- Overweight 12 trialsAll Overweight trials
- COVID-19 11 trialsAll COVID-19 trials
- Type 2 diabetes 10 trialsAll Type 2 diabetes trials
- Rheumatoid arthritis 10 trialsAll Rheumatoid arthritis trials
- Systemic lupus erythematosus 9 trialsAll Systemic lupus erythematosus trials
- All Chronic obstructive pulmonary disease (COPD) trials
- Breast neoplasms 8 trialsAll Breast neoplasms trials
- Heart failure 8 trialsAll Heart failure trials
- Diabetes 8 trialsAll Diabetes trials
- All Chronic obstructive pulmonary disease trials
- Atrial fibrillation 7 trialsAll Atrial fibrillation trials
- All Pulmonary disease, chronic obstructive trials
- Chronic kidney disease 6 trialsAll Chronic kidney disease trials